# Yanling Cao

> Yanling Cao is a Series A investor at Boyu Capital backing Life Science and Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Boyu Capital](https://shizune.co/investors/profile/boyu-capital)
- Location: Cambridge, United States
- Total investments: 2
- Last investment: Nov 2020
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/yanling-cao-b48aa017/

Yanling Cao is a Series A investor at Boyu Capital in Cambridge focused on Life Science and Biotechnology. Yanling Cao

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Life Science | 2 | 100% |
| Biotechnology | 2 | 100% |
| Therapeutics | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 1 | 50% |
| United States | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| D3 Bio | D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path. | $200M | Series A | Nov 17, 2020 |  |
| LifeMine Therapeutics | Discovering powerful new drugs from eukaryotic microbes by combining Genomics with AI and Synthetic Biology. Founded by Gregory Verdine, PhD, Rick Klausner, MD and WeiQing Zhou, MBA, LifeMine Therapeutics is headquartered in Cambridge, Massachusetts. | $70M | Series A | Sep 18, 2017 |  |

2 of 2 investments shown.

## Co-investors
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund, 1 deal together
- [Blue Pool Capital](https://shizune.co/investors/profile/blue-pool-capital) — VC Fund, 1 deal together
- [Foresite Capital](https://shizune.co/investors/profile/foresite-capital) — VC Fund, 1 deal together
- [Merck](https://shizune.co/investors/profile/merck-co-inc) — VC Fund, 1 deal together
- [MRL Ventures Fund](https://shizune.co/investors/profile/mrl-venture-fund) — VC Fund, 1 deal together
- [WuXi AppTec](https://shizune.co/investors/profile/wuxi-apptec) — VC Fund, 1 deal together

## About Boyu Capital

VC Fund · Beijing, China

Boyu Capital Consultancy Co. Ltd is a private equity firm specializing in investments in China. Boyu Capital Consultancy Co. Ltd was founded on September 28, 2010 and is based in Hong Kong with an additional office in Beijing, China.

2 contacts available at Boyu Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Mary Ma | Co-Founder and Chairman | https://shizune.co/investors/profile/mary-ma |
| Yanling Cao | Managing Director | https://shizune.co/investors/profile/yanling-cao |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Yanling Cao invest in?

Yanling Cao invests primarily in Life Science, Biotechnology and Therapeutics startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Yanling Cao last invest?

The most recent investment recorded for Yanling Cao closed in Nov 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co